Narrative review / 2012
A review indicates endocrine-disrupting chemicals frequently exhibit low-dose effects and nonmonotonic dose-response curves linked to human health outcomes.
This review evaluates mechanistic and literature evidence on low-dose effects and nonmonotonic dose-response curves of endocrine-disrupting chemicals (EDCs). It reviews mechanistic data, uses a weight-of-evidence approach to analyze five examples, and discusses hundreds of examples from cell culture, animal, and epidemiology studies. The authors report that nonmonotonic responses and low-dose effects are remarkably common, and epidemiological evidence associates EDC exposures with human diseases and disabilities. They conclude that low-dose effects cannot be predicted from high doses when nonmonotonic curves occur, necessitating changes in chemical testing and safety determination.
Shows an association, not proof of cause and effect.
- Study type
- Narrative review
- Who was studied
- Humans, animals, and cell cultures from reviewed literature
- What was measured
- Low-dose effects and nonmonotonic dose responses of EDCs
THE PAPER
Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses.
Vandenberg LN, Colborn T, Hayes TB, Heindel JJ, Jacobs DR, Lee DH, Shioda T, Soto AM, vom Saal FS, Welshons WV, Zoeller RT, Myers JP. Endocr Rev, 2012.
PubMed 22419778 ↗DOI 10.1016/j.atherosclerosis.2011.1005.1001 ↗
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.